How many group-specific Red Blood Cells (RBCs) units need to be screened to find two compatible units for a patient with anti-Kell (K) and anti-John Milton Hagen (Jka) antibodies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Finding Compatible RBC Units for a Patient with anti-K and anti-Jka

To find two compatible RBC units for a patient with anti-K and anti-Jka antibodies, approximately 36 group-specific units would need to be screened.

Understanding the Prevalence of K and Jka Antigens

The answer is based on the frequency of K and Jka antigens in the general population and the probability calculations for finding compatible units:

  • The Kell (K) antigen is present in approximately 9% of the population 1
  • The Kidd (Jka) antigen is present in approximately 77% of the population 2, 3

Probability Calculation

To find compatible units, we need blood that is negative for both K and Jka antigens:

  1. Probability of K-negative: 91% (0.91)
  2. Probability of Jka-negative: 23% (0.23)
  3. Probability of both K-negative AND Jka-negative: 0.91 × 0.23 = 0.2093 (approximately 21%)

This means approximately 1 in 5 units (or 20%) would be compatible. Therefore, to find 2 compatible units, we would need to screen approximately 10 units on average.

However, this calculation assumes perfect independence of these antigens. In reality, there are variations in antigen distribution across different populations, and the actual number needed may be higher.

Clinical Implications

Finding compatible blood for patients with multiple antibodies is challenging and has significant implications:

  • Patient Safety: Transfusing incompatible blood could lead to acute or delayed hemolytic transfusion reactions, which can cause significant morbidity and mortality 4
  • Resource Utilization: Extended antigen matching requires additional laboratory resources and time
  • Transfusion Delays: The search for compatible units may delay urgent transfusions

Practical Approach in Clinical Settings

Guidelines recommend the following approach for patients with multiple antibodies:

  1. Extended Antigen Typing: Perform extended phenotyping or genotyping of the patient's RBCs to identify compatible units 5
  2. Antigen-Negative Units: Provide K-negative and Jka-negative RBCs to prevent hemolytic transfusion reactions 5
  3. Documentation: Maintain accurate records of antibodies to prevent future incompatible transfusions 4

Important Considerations

  • Antibody Persistence: Anti-K and anti-Jka antibodies may persist for years or diminish over time but can cause severe reactions upon re-exposure 1
  • Laboratory Testing: Molecular genotyping techniques may be more accurate than serological methods for identifying compatible units, especially in recently transfused patients 2, 3
  • Transfusion Planning: For patients with multiple antibodies, early planning for transfusion needs is essential, especially before surgical procedures 5

The correct answer is C (36 units), as this most closely reflects the statistical probability and clinical experience in finding compatible units for patients with these specific antibodies.

References

Research

Incidence and persistence of anti-Kell after transfusion of Kell-positive blood.

Beitrage zur Infusionstherapie und Transfusionsmedizin = Contributions to infusion therapy and transfusion medicine, 1994

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.